iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.308
-0.011 (-3.51%)
At close: Jul 12, 2024, 4:00 PM
0.297
-0.011 (-3.54%)
After-hours: Jul 12, 2024, 7:59 PM EDT

Company Description

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide.

Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.

The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them.

It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions.

iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

iSpecimen Inc.
iSpecimen logo
Country United States
Founded 2009
IPO Date Jun 17, 2021
Industry Diagnostics & Research
Sector Healthcare
Employees 53
CEO Ms. Tracy Wilson Curley

Contact Details

Address:
450 Bedford Street, Suite 1010
Lexington, Massachusetts 02420
United States
Phone 781-301-6700
Website ispecimen.com

Stock Details

Ticker Symbol ISPC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $8.00
CIK Code 0001558569
CUSIP Number 45032V108
ISIN Number US45032V1089
Employer ID 27-0480143
SIC Code 8731

Key Executives

Name Position
Tracy Wilson Curley Chief Executive Officer, Chief Financial Officer, Treasurer and Director
Benjamin Bielak Chief Information Officer and Secretary
Carly Lejnieks Vice President of Marketing
Annette Arnold Vice President of Sales and Business Development
David Wages M.D., Ph.D. Chief Medical Officer
Eric Langlois Chief Revenue Officer
Evan Cox Senior Vice President of Strategy and Innovation

Latest SEC Filings

Date Type Title
Jul 9, 2024 SCHEDULE 13G/A Filing
Jul 8, 2024 8-K Current Report
Jul 3, 2024 8-K Current Report
Jun 10, 2024 ARS Filing
Jun 10, 2024 DEF 14A Other definitive proxy statements
May 28, 2024 PRER14A Filing
May 17, 2024 8-K Current Report
May 7, 2024 8-K Current Report
May 7, 2024 10-Q Quarterly Report
Apr 11, 2024 8-K Current Report